Literature DB >> 23644367

Catheter-based treatment of ilio-femoral deep vein thrombosis - an update on current evidence.

Jennifer Fahrni1, Rolf Peter Engelberger, Nils Kucher, Torsten Willenberg, Iris Baumgartner.   

Abstract

Ilio-femoral deep vein thrombosis (DVT) has a high rate of long-term morbidity in the form of the postthrombotic syndrome (PTS). Therefore, management of acute thrombosis should not only focus on the prevention of acute complications such as propagation or embolisation of the initial clot but also on preventing PTS and recurrent thrombosis. Contemporary catheter-based treatments of deep vein thrombosis have proven to be safe and effective in selected patients. Current guidelines recommend medical therapy with anticoagulation alone for all but the most severe, limb-threatening thrombosis. They additionally allow for consideration of catheter-based treatment in patients with acute DVT and low risk of bleeding complications to prevent PTS. Recent studies favoring interventional therapy have not been included in these guidelines. Data on long-term outcome is expected to be published soon, clarifying and very likely strengthening the role of catheter-based treatments in the management of acute ilio-femoral DVT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644367     DOI: 10.1024/0301-1526/a000264

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis.

Authors:  Xiao-Long Du; Ling-Shang Kong; Qing-You Meng; Aimin Qian; Wen-Dong Li; Hong Chen; Xiao-Qiang Li; Cheng-Long Li
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

2.  Cancer associated phlegmasia cerulea dolens successfully treated with apixaban.

Authors:  Irene García-Fernández-Bravo; Pablo Demelo-Rodríguez; Lucia Ordieres-Ortega; Arturo Álvarez-Luque; Jorge Del Toro-Cervera
Journal:  Blood Res       Date:  2018-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.